Escherichia fergusonii Promotes Nonobese Nonalcoholic Fatty Liver Disease by Interfering With Host Hepatic Lipid Metabolism Through Its Own msRNA 23487
Feng‐Zhi Xin(Shanghai Jiao Tong University), Jian‐Gao Fan(Shanghai Jiao Tong University), Rui-Nan Zhang(Shanghai Jiao Tong University), Chao Sun(Tianjin Medical University General Hospital), Zizhen Gong(XinHua Hospital), Qianren Zhang(Shanghai Jiao Tong University), Lin Ye(Shanghai Chest Hospital), Zixuan Wang(Shanghai Jiao Tong University), Xiaolin Liu(Hebei Medical University), Mengyu Wang(Shanghai Jiao Tong University), Lin Zeng, Zehua Zhao(Shanghai Jiao Tong University), Lei‐Jie Huang(Shanghai Jiao Tong University), Qin Pan(XinHua Hospital), Feng Shen(Shanghai Jiao Tong University), Lu Jiang(Shanghai Jiao Tong University)
Cited by 71
Related Papers
Identification of antimicrobial peptides from the human gut microbiome using deep learning
|Nature Biotechnology|2022|470
Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats
|Experimental & Molecular Medicine|2019|337
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
|Nature Communications|2020|247
Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression
|Experimental & Molecular Medicine|2018|212